A Bruce Lyons

5PUBLICATIONS
10CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 19, 2022
Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours.

Chrissie E B Ong, Yuanyuan Cheng, Hannah V Siddle

|Jul 16, 2021
Cytokines: Signalling Improved Immunotherapy?

Alana J De Luca, A Bruce Lyons, Andrew S Flies

|Apr 02, 2021
NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers.

Chrissie E B Ong, Amanda L Patchett, Jocelyn M Darby

|Apr 05, 2020
A Devil of a Transmissible Cancer.

Gregory M Woods, A Bruce Lyons, Silvana S Bettiol

|Jan 24, 2020
An oral bait vaccination approach for the Tasmanian devil facial tumor diseases.

Andrew S Flies, Emily J Flies, Samantha Fox

Pageof 1